Michael B. Nicholl

1.4k total citations
30 papers, 1.1k citations indexed

About

Michael B. Nicholl is a scholar working on Immunology, Oncology and Surgery. According to data from OpenAlex, Michael B. Nicholl has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 11 papers in Oncology and 7 papers in Surgery. Recurrent topics in Michael B. Nicholl's work include Immunotherapy and Immune Responses (6 papers), CAR-T cell therapy research (4 papers) and Sirtuins and Resveratrol in Medicine (4 papers). Michael B. Nicholl is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), CAR-T cell therapy research (4 papers) and Sirtuins and Resveratrol in Medicine (4 papers). Michael B. Nicholl collaborates with scholars based in United States, China and India. Michael B. Nicholl's co-authors include Yujiang Fang, Myung‐Shin Sim, Donald L. Morton, Dave S.�B. Hoon, Vincent G. DeMarco, Qian Bai, William Conway, Roderick R. Turner, Christine Kuo and Tung Nguyen and has published in prestigious journals such as PLoS ONE, Annals of Surgery and Scientific Reports.

In The Last Decade

Michael B. Nicholl

28 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael B. Nicholl United States 18 399 377 285 199 174 30 1.1k
Konstantinos Lasithiotakis Greece 19 797 2.0× 590 1.6× 127 0.4× 321 1.6× 282 1.6× 66 1.5k
Yan Zhu China 21 399 1.0× 518 1.4× 151 0.5× 205 1.0× 243 1.4× 69 1.3k
Olivier Romano France 10 267 0.7× 254 0.7× 82 0.3× 186 0.9× 106 0.6× 14 827
Qing Yang China 24 615 1.5× 947 2.5× 195 0.7× 154 0.8× 326 1.9× 96 2.0k
Cheng Ean Chee Singapore 18 465 1.2× 955 2.5× 146 0.5× 158 0.8× 203 1.2× 73 1.9k
Mark Hong Lee South Korea 13 245 0.6× 383 1.0× 84 0.3× 112 0.6× 135 0.8× 63 904
Naoki Hiramatsu Japan 21 204 0.5× 629 1.7× 190 0.7× 188 0.9× 89 0.5× 65 1.8k
Yasutaka Shuno Japan 17 344 0.9× 393 1.0× 73 0.3× 197 1.0× 128 0.7× 53 1.1k
Masaya Hiyoshi Japan 18 376 0.9× 652 1.7× 88 0.3× 167 0.8× 138 0.8× 45 1.2k
Joji Tani Japan 21 434 1.1× 712 1.9× 306 1.1× 246 1.2× 249 1.4× 125 1.7k

Countries citing papers authored by Michael B. Nicholl

Since Specialization
Citations

This map shows the geographic impact of Michael B. Nicholl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael B. Nicholl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael B. Nicholl more than expected).

Fields of papers citing papers by Michael B. Nicholl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael B. Nicholl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael B. Nicholl. The network helps show where Michael B. Nicholl may publish in the future.

Co-authorship network of co-authors of Michael B. Nicholl

This figure shows the co-authorship network connecting the top 25 collaborators of Michael B. Nicholl. A scholar is included among the top collaborators of Michael B. Nicholl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael B. Nicholl. Michael B. Nicholl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xuhui, Chenglu Qin, Christian J. Nelson, et al.. (2023). The Novel Use of IL-28 as an Effective Radiosensitizer in Pancreatic Cancer. Anticancer Research. 43(5). 1885–1890.
2.
Khoobchandani, Menka, Aslam A. Khan, Kavita Katti, et al.. (2021). Green nanotechnology of MGF-AuNPs for immunomodulatory intervention in prostate cancer therapy. Scientific Reports. 11(1). 16797–16797. 47 indexed citations
3.
Kosturakis, Alyssa K., et al.. (2018). First 100 consecutive robotic inguinal hernia repairs at a Veterans Affairs hospital. Journal of Robotic Surgery. 12(4). 699–704. 21 indexed citations
4.
Fang, Yujiang, Lei Zhao, Huaping Xiao, et al.. (2017). IL-33 acts as a foe to MIA PaCa-2 pancreatic cancer. Medical Oncology. 34(2). 23–23. 28 indexed citations
5.
Zhu, Ziwen, Huaping Xiao, Mark R. Wakefield, et al.. (2017). Unveil the mysterious mask of cytokine-based immunotherapy for melanoma. Cancer Letters. 394. 43–51. 11 indexed citations
6.
MacArthur, Kelly M., Brian C. Baumann, & Michael B. Nicholl. (2016). Laparoscopic Versus Open Resection for Gastrointestinal Stromal Tumors (GISTs). Journal of Gastrointestinal Cancer. 48(1). 20–24. 11 indexed citations
7.
Fang, Yujiang & Michael B. Nicholl. (2014). A Dual Role for Sirtuin 1 in Tumorigenesis. Current Pharmaceutical Design. 20(15). 2634–2636. 14 indexed citations
8.
Nicholl, Michael B., Xuhui Chen, Qian Bai, et al.. (2014). IL-35 promotes pancreas cancer growth through enhancement of proliferation and inhibition of apoptosis: Evidence for a role as an autocrine growth factor. Cytokine. 70(2). 126–133. 70 indexed citations
9.
Fang, Yujiang, et al.. (2013). A potential role for resveratrol as a radiation sensitizer for melanoma treatment. Journal of Surgical Research. 183(2). 645–653. 46 indexed citations
10.
Nicholl, Michael B., et al.. (2013). Repeat PEG placement is safe for head and neck cancer patients. American Journal of Otolaryngology. 35(2). 89–92. 4 indexed citations
11.
Fang, Yujiang, Vincent G. DeMarco, & Michael B. Nicholl. (2012). Resveratrol enhances radiation sensitivity in prostate cancer by inhibiting cell proliferation and promoting cell senescence and apoptosis. Cancer Science. 103(6). 1090–1098. 94 indexed citations
12.
Fang, Yujiang, et al.. (2012). A Possible Role for Perforin and Granzyme B in Resveratrol‐Enhanced Radiosensitivity of Prostate Cancer. Journal of Andrology. 33(4). 752–760. 45 indexed citations
13.
Nguyen, Tung, Christine Kuo, Michael B. Nicholl, et al.. (2011). Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma. Epigenetics. 6(3). 388–394. 152 indexed citations
14.
Nicholl, Michael B., David Elashoff, Hiroya Takeuchi, Donald L. Morton, & Dave S.�B. Hoon. (2010). Molecular Upstaging Based on Paraffin-Embedded Sentinel Lymph Nodes. Annals of Surgery. 253(1). 116–122. 33 indexed citations
15.
Nicholl, Michael B., et al.. (2010). Small Bowel Adenocarcinoma: Understaged and Undertreated?. Annals of Surgical Oncology. 17(10). 2728–2732. 47 indexed citations
16.
Conway, William, Mark B. Faries, Michael B. Nicholl, et al.. (2009). Age-Related Lymphatic Dysfunction in Melanoma Patients. Annals of Surgical Oncology. 16(6). 1548–1552. 89 indexed citations
17.
Huang, Sharon K., Marlene Darfler, Michael B. Nicholl, et al.. (2009). LC/MS-Based Quantitative Proteomic Analysis of Paraffin-Embedded Archival Melanomas Reveals Potential Proteomic Biomarkers Associated with Metastasis. PLoS ONE. 4(2). e4430–e4430. 56 indexed citations
18.
Nicholl, Michael B. & Anton J. Bilchik. (2007). Thermal ablation of hepatic malignancy: Useful but still not optimal. European Journal of Surgical Oncology. 34(3). 318–323. 17 indexed citations
19.
Lodge, Andrew, Ping Yu, Michael B. Nicholl, et al.. (2006). CD40 ligation restores cytolytic T lymphocyte response and eliminates fibrosarcoma in the peritoneum of mice lacking CD4+ T cells. Cancer Immunology Immunotherapy. 55(12). 1542–1552. 6 indexed citations
20.
Nicholl, Michael B., Andrew Lodge, Ian E. Brown, & Sonia L. Sugg. (2004). Restored immune response to an MHC-II-Restricted antigen in tumor-bearing hosts after elimination of regulatory T cells. Journal of Pediatric Surgery. 39(6). 941–946. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Konstantinos Lasithiotakis Breakdown of academic impact, for papers by Yan Zhu Breakdown of academic impact, for papers by Olivier Romano Breakdown of academic impact, for papers by Qing Yang Breakdown of academic impact, for papers by Cheng Ean Chee Breakdown of academic impact, for papers by Mark Hong Lee Breakdown of academic impact, for papers by Naoki Hiramatsu Breakdown of academic impact, for papers by Yasutaka Shuno Breakdown of academic impact, for papers by Masaya Hiyoshi Breakdown of academic impact, for papers by Joji Tani
Rankless by CCL
2026